3462 results for «2023»
3462 results
How to support the equal advancement of women in interventional cardiology
18 May 2023 – From EuroPCR 2023
Roxana Mehran, Marta Bande and Emanuele Barbato tackle the issue of gender equity: how to create a more equitable environment for women interventional cardiologists, and how to support women in the field of interventional cardiology as a whole. They also discuss the key drivers of change...
Durability of surgical and transcatheter valves, what do we know so far?
16 May 2023 – From EuroPCR 2023
We have significant new data that highlights the long-lasting effectiveness of transcatheter devices, which brings forth a promising possibility of them competing with surgical valves in the next generation. Take part in a discussion with Bernard Prendergast and Raj Makkar as they analyze the data available so far...
The PECTUS trial, OCT for identification of vulnerable plaques and its impact on clinical outcomes
16 May 2023 – From EuroPCR 2023
Niels Van Royen and Lorenz Räber discuss a very emerging topic: the vulnerable plaque, and more specifically the related PECTUS Trial. They address the question of why vulnerable plaques should be detected and what can be done with the results, before looking at the study design...
Latest evidences and experiences on ultra-thin strut stenting
17 May 2023 – From EuroPCR 2023
Suhas Hardas, Anupam Jena and Rajneesh Kapoor discuss ultra-thin strut stent technology.
When do we really call the new-generation stents "ultra-thin strut strents"? Why do we need stents of this type? Which lesions, or which patients, will they be most useful and effective for?
Find out more about...
Learnings and perspectives from the Asian STEMI Registry
16 May 2023 – From EuroPCR 2023
Deanna Khoo invites Paul Ong and Michael K. Y. Lee, the Principal Investigators of the study, to present the results of the BioFreedom Asian Registry, which focused on the management of STEMI patients in Asia.
Find out more about the study design, before discovering the main outcomes!
This interview...
At PCR, it’s all about people!
17 May 2023
EuroPCR – the 2023 edition – has been prepared with a new Core Team. Indeed, Jean Fajadet and William Wijns invited three new Course Directors to join them in this role at the end of last year. It was all part of a general reorganisation of PCR’s structure, during...
EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!
20 May 2025
Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...
Introducing our recognised EuroPCR Networkers!
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...
Author
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
How can the latest long-term TAVI evidence impact our daily decision-making?
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at...
Treating a wide range of patient anatomies with the PASCAL implants
06 Dec 2023 – From PCR London Valves 2023
Sam Dawkins, Niklas Schofer and Mirjam Wild share the latest experience on Pascal implants for mitral and tricuspid TEER. Together they discuss the rationale for using the same device for mitral and tricuspid, how the skills and knowledge on MR can be used for TR,...
The revolution coming to tricuspid valve treatment with the EVOQUE replacement system
06 Dec 2023 – From PCR London Valves 2023
Marianna Adamo and Philipp Lurz summarize the results of the TRISCEND II randomized trial which addresses the question of transcatheter tricuspid replacement (using the EVOQUE system) vs OMT. Find out more about the key findings at 6 months and the relevance for your practice
This interview was...
Recent clinical evidence for mitral TEER the CLASP IID trial
06 Dec 2023 – From PCR London Valves 2023
What is the CLASP IID registry and what are the key learnings from 1-year data? Philipp Lurz and Jörg Hausleiter describe the methodology of the programme which compares Pascal vs Mitraclip in patients with degenerative mitral regurgitation. Discover the key findings which are relevant to your practice.
This...
